Global Anal Fistula Treatment Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Anal Fistula Treatment Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Anal fistula is a tract between the epithelial surface of the rectum and the perianal area. There are several glands in anus which sometimes get blocked or clogged. This leads to bacterial infection and results into swelling around the infected tissues. Anal fistula treatment involves use of both surgical and non-surgical approaches for effective removal of anal fistulae in patients.

Market Overview:

The latest research study on the global Anal Fistula Treatment market finds that the global Anal Fistula Treatment market reached a value of USD 742.12 million in 2022. It’s expected that the market will achieve USD 970.13 million by 2028, exhibiting a CAGR of 4.57% during the forecast period.

Market Driving Force

Increase in the number of cases of inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis across the world is a significant economic burden on the health care systems in several countries. Around 0.3% people in the industrialized countries have IBD. A report published in the Crohn’s & Colitis Foundation of America (CCFA) stated that nearly 1.6 million people in the U.S were affected with IBD in 2014, with 70,000 new cases reported each year. Of the total number of people with IBD in the U.S., 780,000 people had Crohn’s disease, while 907,000 had ulcerative colitis. Therefore, the increase in the patient population is expected to drive demand for surgical as well as non-surgical interventions for the treatment of anal fistula. This in turn is likely to boost the growth of the market during the forecast period.

Market Risk

Anal fistula is a condition that is costly for society and that the burden of anal fistula in terms of health care resources is especially high for patients experiencing multiple surgeries. For most patients, they had more than one surgery and on average these patients underwent over four surgeries.
Although and anal fistula surgery is covered by most medical insurance policies, in some developing countries where people have limited income and less developed healthcare infrastructure, patients may be discouraged from treatment due to high costs. Although the cost of surgery for an anal fistula will depend on the exact type of surgery, the price is not cheap.

Therefore, the high cost associated with the procedure such as cost of surgery & the post-operative treatments, as well as the treatment options available are expected to act as restraints to the market growth
Nowadays, more and more people suffer from anal fistula, but most people don't take it seriously, thinking that the disease is not very harmful and will not produce any adverse effects. In fact, this is not the case. Anal fistula is very harmful. If it is not treated in time after it occurs, it will aggravate the condition and even have the possibility of cancer. And lack of awareness regarding the disease and the treatments available in the market are expected to restrain the market growth The fact remains that an “ideal” procedure for anal fistula remains elusive. The failure of each sphincter-preserving procedure (30%50% recurrence) often results in multiple operations. In essence, the price of preservation of continence at all cost is multiple and often different operations, prolonged disability and disappointment for the patient and the surgeon.
The aim of surgical therapy of fistula is cure. If one is too aggressive
with fistulotomy, cure may be achieved at a cost of incontinence. On the other hand, being too conservative, while striving to maintain continence, will result in recurrence or persistence of the fistula. Therefore, there is a long way to go before patients can boldly seek treatment without worrying recurrence.

Region Overview:

From 2023-2028, North America is estimated to witness robust growth prospects.

Company Overview:

Mayo Clinic is one of the major players operating in the Anal Fistula Treatment market, holding a share of 1.41% in 2021.

Mayo Clinic, a not-for-profit medical group practice, provides medical care, research, and education services. It offers medical care services in various specialties, including diabetes and endocrinology, gastroenterology, gynecology, cancer, neurology and neurosurgery, orthopedics, pulmonology, rheumatology, nephrology, urology, and cardiology andheart surgery.

Cleveland Clinic is a non-profit academic medical center that integrates clinical and hospital care with research and education.

The mission of Cleveland Clinic is to provide better care of the sick, investigation into their problems, and further education of those who serve.

Segmentation Overview:

Among different product types, Fistulotomy segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Intersphincteric Fistula segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Anal Fistula Treatment market covered in Chapter 3:

The Johns Hopkins Hospital
Aurobindo pharma
Exapharma
Pfizer
Baxter
Tianjin People's Hospital
Johnson & Johnson
Biolitec AG
Charité
Vivostat A / S
Mylan
Teva
The Sixth Affiliated Hospital of Sun Yat-sen University
Cleveland Clinic
Mayo Clinic
CSL Behring

In Chapter 4 and Chapter 14.2, on the basis of types, the Anal Fistula Treatment market from 2018 to 2029 is primarily split into:

Fistulotomy
Seton Techniques
Advancement Flap Procedures
Fibrin Glue
Bioprosthetic Plug

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Anal Fistula Treatment market from 2018 to 2029 covers:

Extrasphincteric Fistula
Suprasphincteric Fistula
Transphincteric Fistula
Intersphincteric Fistula
Submucosal Fistula

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)